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Despite	  straightforward	  guidelines	  on	  brain	  death	  determination	  by	  the	  American	  
Academy	  of	  Neurology	  (AAN),	  substantial	  practice	  variability	  exists	  internationally,	  
between	  states,	  and	  among	  institutions.	  We	  created	  a	  simulation-­‐based	  training	  
course	  on	  proper	  determination	  based	  on	  the	  AAN	  practice	  parameters	  to	  address	  
and	  assess	  knowledge	  and	  practice	  gaps	  at	  our	  institution.	  Our	  intervention	  
consisted	  of	  a	  didactic	  course	  and	  a	  simulation	  exercise,	  and	  was	  bookended	  by	  
before	  and	  after	  multiple-­‐choice	  tests.	  The	  40-­‐minute	  didactic	  course,	  including	  a	  
video	  demonstration,	  covered	  all	  aspects	  of	  the	  brain	  death	  examination.	  Simulation	  
sessions	  utilized	  a	  SimMan	  3G	  manikin,	  and	  involved	  a	  complete	  examination,	  
including	  an	  apnea	  test.	  Possible	  confounders	  and	  signs	  incompatible	  with	  brain	  
death	  were	  embedded	  throughout.	  Facilitators	  evaluated	  performance	  with	  a	  26-­‐
point	  checklist	  based	  on	  the	  most	  recent	  AAN	  guidelines.	  One	  hundred	  eleven	  
physicians	  from	  multiple	  specialties	  have	  participated	  in	  the	  didactic	  session,	  and	  38	  
have	  completed	  the	  simulation.	  Pre-­‐test	  scores	  were	  poor	  (41.4%),	  with	  attendings	  
scoring	  higher	  than	  residents	  (46.6%	  vs.	  40.4%,	  p=0.07),	  and	  neurologists	  and	  
neurosurgeons	  significantly	  outperforming	  other	  specialists	  (53.9%	  vs.	  38.9%,	  
p=0.003).	  Post-­‐test	  scores	  (73.3%)	  were	  notably	  higher	  than	  pre-­‐test	  scores	  
(45.4%).	  	  Participant	  feedback	  has	  been	  uniformly	  positive.	  Baseline	  knowledge	  of	  
brain	  death	  determination	  among	  providers	  was	  low	  but	  improved	  greatly	  after	  the	  
course.	  In	  conclusion,	  our	  intervention	  represents	  an	  effective	  model	  that	  can	  be	  
replicated	  at	  other	  institutions	  to	  train	  clinicians	  in	  the	  determination	  of	  brain	  death	  
according	  to	  evidence-­‐based	  guidelines.	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Introduction	  
	  
Historical	  Context	  	  
	   Prior	  to	  the	  mid-­‐twentieth	  century,	  the	  concept	  of	  brain	  death	  did	  not	  exist.	  
In	  fact,	  there	  was	  essentially	  no	  need	  to	  define	  death	  in	  precise	  terms,	  as	  respiratory	  
and	  circulatory	  arrest	  inevitably	  led	  to	  loss	  of	  function	  of	  all	  organ	  systems.	  At	  this	  
time,	  severe	  and	  irreversible	  brain	  injury	  inevitably	  led	  to	  respiratory	  arrest	  
secondary	  to	  insufficient	  breathing	  drive	  and	  an	  inability	  to	  maintain	  patency	  of	  the	  
upper	  airway,	  which	  would	  eventually	  trigger	  circulatory	  arrest—fulfilling	  the	  
“cardiopulmonary”	  definition	  of	  death	  (1).	  In	  this	  way,	  loss	  of	  function	  of	  the	  brain	  
and	  brainstem	  was	  inextricably	  linked	  to	  the	  loss	  of	  circulatory	  and	  respiratory	  
function.	  However,	  in	  the	  1950s,	  the	  introduction	  of	  endotracheal	  intubation	  to	  
preserve	  respiratory	  function	  allowed	  for	  widespread	  use	  of	  mechanical	  ventilation	  
in	  intensive	  care	  units	  (ICU)	  (1,2).	  Additionally,	  a	  decade	  earlier	  the	  first	  successful	  
cardiac	  defibrillation	  was	  performed,	  which	  allowed	  for	  resuscitation	  of	  patients	  
with	  severe	  –	  and	  previously	  irreversible	  –	  cardiopulmonary	  injury	  (3).	  This	  created	  
a	  novel	  scenario:	  with	  the	  help	  of	  the	  mechanical	  ventilator,	  patients	  who	  had	  
suffered	  catastrophic	  and	  irreversible	  brain	  injury	  could	  now	  be	  maintained	  with	  
adequate	  cardiopulmonary	  function,	  and	  the	  death	  of	  the	  brain	  could	  temporarily	  be	  
dissociated	  from	  respiratory	  and	  circulatory	  function.	  Thus,	  there	  emerged	  a	  need	  
to	  define	  this	  state—both	  to	  provide	  finality	  for	  families	  and	  to	  preserve	  vital	  ICU	  
resources.	  	  
	   The	  characterization	  of	  this	  novel	  neurologic	  state	  began	  with	  the	  French	  
neurologists	  Mollaret	  and	  Goulon’s	  1959	  article	  “Le	  Coma	  Dépassé.”	  In	  it,	  they	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described	  23	  cases	  of	  coma,	  the	  severity	  of	  which	  clinically	  surpassed	  anything	  
described	  in	  the	  literature	  to	  that	  point.	  They	  provided	  the	  first	  comprehensive	  
clinical	  and	  EEG	  description	  of	  “the	  irretrievable	  coma,”	  and	  were	  also	  the	  first	  to	  
distinguish	  it	  from	  other	  comatose	  states	  (4).	  The	  paper	  was	  initially	  overlooked	  
outside	  of	  France,	  but	  it	  would	  eventually	  set	  the	  stage	  for	  further	  development	  and	  
application	  of	  the	  concept	  of	  brain	  death	  (1).	  	  	  
	   In	  the	  United	  States,	  the	  pressure	  to	  develop	  criteria	  for	  the	  irreversible	  
coma	  came	  from	  two	  groups:	  physicians	  working	  with	  critically	  ill	  patients,	  who	  
wanted	  to	  better	  define	  when	  care	  was	  futile,	  and	  transplant	  surgeons,	  who	  
recognized	  the	  possibilities	  created	  by	  a	  new	  pool	  of	  eligible,	  high	  quality	  organ	  
donors.	  This	  push	  was	  not	  without	  controversy—many	  transplant	  surgeons	  did	  not	  
feel	  comfortable	  harvesting	  organs	  from	  patients	  who	  had	  not	  fulfilled	  the	  
cardiopulmonary	  definition	  of	  death,	  and	  some	  felt	  that	  this	  practice	  would	  cause	  
the	  field	  of	  transplantation	  to	  fall	  into	  disrepute	  with	  the	  rest	  of	  the	  medical	  
profession	  (1).	  Nonetheless,	  in	  1968	  the	  Ad	  Hoc	  Committee	  of	  Harvard	  Medical	  
School,	  which	  included	  neurologists,	  a	  neurosurgeon,	  an	  ethicist,	  and	  an	  
anesthesiologist	  convened,	  with	  the	  goal	  of	  “defin[ing]	  irreversible	  coma	  as	  a	  new	  
definition	  for	  death”	  (5).	  They	  produced	  a	  set	  of	  guidelines	  titled	  “A	  Definition	  of	  
Irreversible	  Coma.”	  
These	  guidelines	  were	  largely	  accepted	  among	  members	  of	  the	  medical	  
community,	  and	  prompted	  the	  development	  of	  similar	  criteria	  in	  the	  United	  
Kingdom	  and	  other	  nations.	  However,	  the	  guidelines	  had	  not	  yet	  gained	  any	  traction	  
within	  the	  legal	  community	  (1).	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  In	  1981,	  the	  President’s	  Commission	  for	  the	  Study	  of	  Ethical	  Problems	  in	  
Medicine	  and	  Biomedical	  and	  Behavioral	  Research	  published	  guidelines	  defining	  
brain	  death	  as	  the	  irreversible	  cessation	  of	  all	  function	  of	  the	  entire	  brain,	  including	  
the	  brainstem	  (6).	  The	  Uniform	  Determination	  of	  Death	  Act	  (UDDA)(7)	  is	  based	  
directly	  on	  these	  seminal	  guidelines.	  The	  act	  forms	  the	  basis	  for	  brain	  death	  laws	  in	  
the	  United	  States,	  and	  since	  it	  was	  drafted	  in	  1981	  has	  been	  adopted	  by	  all	  50	  states	  
and	  the	  District	  of	  Columbia.	  The	  UDDA	  states:	  “An	  individual	  who	  has	  sustained	  
either	  1)	  irreversible	  cessation	  of	  circulatory	  and	  respiratory	  functions,	  or	  2)	  
irreversible	  cessation	  of	  all	  functions	  of	  the	  entire	  brain,	  including	  the	  brain	  stem,	  is	  
dead.”	  While	  the	  UDDA	  provides	  a	  legal	  framework	  for	  brain	  death,	  it	  does	  not	  spell	  
out	  the	  details	  of	  the	  exam	  that	  would	  allow	  clinicians	  to	  make	  that	  determination.	  
Rather,	  it	  simply	  states	  that	  determination	  of	  death	  must	  be	  made	  “in	  accordance	  
with	  acceptable	  medical	  standards.”	  	  
In	  most	  US	  states,	  all	  physicians	  are	  legally	  permitted	  to	  determine	  brain	  
death.	  Once	  a	  determination	  has	  been	  made,	  there	  will	  be	  no	  criminal	  liability	  
resulting	  from	  removing	  life	  support	  measures,	  except	  in	  New	  Jersey	  and	  New	  York,	  
where	  physicians	  must	  yield	  to	  religious	  objections.	  	  
	  
Diagnosing	  Brain	  Death:	  A	  Review	  of	  the	  AAN	  Practice	  Parameters	  
	   Given	  the	  inherent	  ambiguity	  of	  the	  UDDA,	  the	  American	  Academy	  of	  
Neurology	  (AAN)	  published	  practice	  parameters	  in	  1995(8)	  and	  2010(9)	  to	  guide	  
clinicians	  in	  the	  determination	  of	  brain	  death.	  The	  AAN	  derived	  its	  approach	  from	  
the	  requirements	  of	  the	  UDDA,	  and	  created	  a	  four-­‐step	  protocol	  for	  providers,	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specifying:	  1)	  clinical	  prerequisites	  for	  beginning	  the	  determination	  process,	  2)	  the	  
appropriate	  neurological	  examination	  (including	  apnea	  testing),	  3)	  ancillary	  testing	  
(if	  needed),	  and	  4)	  documentation	  in	  the	  medical	  record.	  Based	  on	  a	  literature	  
review	  done	  as	  part	  of	  the	  2010	  practice	  parameters,	  the	  AAN	  concluded	  that	  there	  
were	  no	  reports	  of	  recovery	  of	  neurological	  function	  after	  a	  determination	  made	  
according	  to	  the	  1995	  AAN	  practice	  parameters.	  Each	  step	  of	  the	  brain	  death	  
determination	  protocol	  will	  be	  reviewed	  here.	  	  All	  steps	  are	  taken	  from	  the	  2010	  
AAN	  practice	  parameters,	  except	  where	  indicated.	  	  
	  
Prerequisites	  
A	  number	  of	  prerequisites	  must	  be	  met	  before	  the	  clinical	  evaluation	  to	  
ensure	  that	  the	  condition	  is	  irreversible.	  First,	  the	  cause	  of	  the	  coma	  must	  be	  
established,	  and	  the	  cause	  must	  be	  irreversible.	  This	  step	  is	  important	  to	  ensure	  that	  
there	  are	  no	  conditions	  that	  may	  be	  mimicking	  brain	  death.	  The	  presence	  of	  central	  
nervous	  system-­‐depressant	  drugs	  must	  be	  excluded:	  by	  plasma	  levels	  or	  calculation	  
of	  clearance	  using	  five	  times	  the	  drug’s	  half-­‐life.	  There	  should	  be	  no	  recent	  
administration	  of	  neuromuscular	  blocking	  agents.	  If	  the	  patient	  had	  been	  drinking	  
alcohol,	  the	  guidelines	  suggest	  that	  the	  examination	  can	  proceed	  with	  a	  blood	  
alcohol	  content	  less	  than	  the	  legal	  limit	  (0.08%).	  The	  guidelines	  also	  mandate	  that	  
there	  be	  no	  severe	  electrolyte,	  acid	  base,	  or	  endocrine	  abnormalities,	  though	  they	  do	  
not	  specify	  exact	  values.	  Prior	  to	  the	  clinical	  exam,	  the	  patient	  must	  also	  achieve	  
normal	  or	  near	  normal	  core	  temperature	  (>36°C)	  and	  normal	  systolic	  blood	  
pressure	  (≥100	  mm	  Hg).	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There	  are	  a	  number	  of	  clinical	  scenarios	  that	  may	  erroneously	  lead	  to	  the	  
impression	  that	  brain	  death	  has	  occurred.	  These	  brain	  death	  mimics,	  which	  include	  
Guillain-­‐Barré	  syndrome,	  baclofen	  overdose,	  organophosphate	  intoxication,	  
lidocaine	  toxicity,	  and	  delayed	  vecuronium	  clearance	  have	  been	  reported	  in	  the	  
literature	  and	  can	  present	  with	  many	  examination	  findings	  consistent	  with	  brain	  
death	  (10-­‐13).	  However,	  the	  AAN	  guidelines	  specify	  that	  the	  cause	  must	  be	  
irreversible	  in	  order	  for	  a	  determination	  to	  occur.	  As	  alluded	  to	  above,	  no	  published	  
case	  of	  a	  brain	  death	  mimic	  has	  involved	  a	  complete	  examination	  according	  to	  the	  
AAN	  practice	  parameters.	  Moreover,	  many	  of	  these	  cases	  had	  at	  least	  one	  
documented	  finding	  that	  is	  inconsistent	  with	  brain	  death	  (9,	  10).	  
	  
Clinical	  Examination	  
Once	  the	  prerequisites	  have	  been	  fulfilled,	  the	  neurologic	  examination	  to	  
determine	  brain	  death	  can	  take	  place.	  The	  goal	  of	  this	  examination	  is	  to	  determine	  if	  
the	  patient	  meets	  the	  three	  cardinal	  criteria	  of	  brain	  death:	  coma,	  brainstem	  
areflexia,	  and	  apnea.	  These	  findings,	  when	  present	  concomitantly	  in	  the	  absence	  of	  
confounders,	  confirm	  irreversible	  cessation	  of	  function	  of	  the	  entire	  brain,	  including	  
the	  brainstem.	  Hence,	  a	  patient	  with	  these	  findings	  is	  brain	  dead,	  and	  legally	  dead	  
according	  to	  the	  UDDA.	  
Coma	  is	  defined	  as	  a	  state	  of	  unarousable	  unresponsiveness	  in	  which	  the	  
patient	  lies	  with	  eyes	  closed	  and	  does	  not	  respond	  appropriately	  to	  stimuli,	  even	  
with	  vigorous	  stimulation.	  Coma	  must	  be	  confirmed	  by	  ensuring	  the	  patient	  lacks	  
evidence	  of	  responsiveness	  to	  auditory,	  motor,	  and	  sensory	  stimulation.	  This	  can	  be	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done	  by	  yelling	  the	  patient’s	  name,	  clapping	  loudly,	  and	  vigorously	  shaking	  the	  
patient’s	  body.	  Response	  to	  noxious	  stimuli	  can	  be	  tested	  by	  applying	  pressure	  to	  
the	  nail	  beds,	  the	  temporomandibular	  joint,	  and	  the	  supraorbital	  ridge.	  	  	  
The	  required	  brainstem	  examination	  is	  thorough,	  and	  includes	  testing	  for	  the	  
following	  reflexes:	  pupillary,	  oculocephalic,	  oculovestibular,	  corneal,	  pharyngeal,	  
and	  tracheal.	  Prior	  to	  oculocephalic	  testing,	  integrity	  of	  the	  cervical	  spine	  must	  be	  
ensured.	  The	  pharyngeal	  reflex	  can	  be	  tested	  by	  stimulation	  of	  the	  posterior	  
pharynx	  with	  an	  object	  or	  suction	  device,	  and	  the	  tracheal	  reflex	  should	  be	  tested	  by	  
providing	  1	  or	  2	  passes	  with	  a	  suction	  catheter	  at	  the	  level	  of	  the	  carina.	  	  
	  
Apnea	  Testing	  
If	  the	  patient’s	  neurologic	  exam	  has	  revealed	  complete	  brainstem	  areflexia,	  
the	  clinician	  should	  proceed	  to	  the	  apnea	  test	  to	  assess	  for	  an	  absence	  of	  breathing	  
drive	  as	  the	  presence	  of	  breathing	  drive	  suggests	  retained	  brainstem	  function.	  
Before	  beginning	  the	  test,	  the	  patient	  should	  be	  preoxygenated	  for	  >10	  minutes	  with	  
100%	  FiO2	  to	  a	  PaO2	  >200	  mm	  Hg,	  and	  the	  PaCO2	  normalized	  to	  35-­‐45	  mm	  Hg	  
(assuming	  no	  known	  CO2	  retention).	  A	  baseline	  blood	  gas	  is	  drawn	  for	  reference.	  
The	  patient	  is	  then	  disconnected	  from	  the	  ventilator,	  and	  oxygenation	  is	  preserved	  
by	  delivering	  100%	  O2	  at	  6	  L/min	  at	  the	  level	  of	  the	  carina	  with	  an	  insufflation	  
catheter.	  For	  the	  next	  8-­‐10	  minutes,	  the	  clinician	  must	  monitor	  closely	  for	  
respiratory	  movements.	  If	  no	  such	  movements	  are	  observed	  during	  this	  time	  period,	  
a	  repeat	  ABG	  is	  drawn	  and	  the	  patient	  is	  placed	  back	  on	  the	  ventilator.	  An	  increase	  
in	  the	  arterial	  PCO2	  to	  ≥60	  mm	  Hg	  (or	  ≥20	  mm	  Hg	  over	  the	  baseline	  value)	  is	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consistent	  with	  brain	  death	  as	  this	  confirms	  absence	  of	  breathing	  drive,	  an	  essential	  
sign	  of	  definitive	  loss	  of	  brainstem	  function.	  If	  the	  patients	  oxygen	  saturation	  is	  
<85%	  for	  >30	  seconds,	  the	  test	  should	  be	  aborted.	  In	  these	  cases,	  the	  procedure	  can	  
be	  repeated	  with	  CPAP	  increased	  to	  10	  cm	  H2O	  and	  the	  100%	  O2	  increased	  to	  
12L/min.	  	  
The	  apnea	  test	  is	  the	  most	  avoided	  part	  of	  the	  brain	  death	  examination	  (14).	  
This	  is	  likely	  due	  to	  fear	  of	  complications,	  which	  have	  been	  reported	  to	  be	  as	  high	  as	  
21%	  (15).	  Other	  studies,	  however,	  show	  that	  serious	  complications	  are	  uncommon	  
when	  the	  patient	  is	  adequately	  preoxygenated	  and	  carefully	  monitored	  during	  the	  
test	  (16,17).	  Unfavorable	  pre-­‐test	  conditions,	  such	  as	  acid-­‐base	  abnormalities,	  
electrolytes	  abnormalities,	  or	  arrhythmias	  significantly	  increase	  the	  risk	  of	  
complications	  (17,18).	  Sedatives	  can	  depress	  the	  respiratory	  drive	  during	  the	  apnea	  
test	  and	  lead	  to	  increased	  pre-­‐test	  pCO2	  (19).	  A	  common	  difficulty	  that	  arises	  with	  
apnea	  testing	  is	  the	  inability	  to	  predict	  how	  quickly	  pCO2	  will	  increase	  once	  the	  
patient	  is	  disconnected	  from	  the	  ventilator	  (20).	  The	  AAN	  practice	  parameters	  
recommend	  8-­‐10	  minutes,	  which	  represents	  the	  average	  time	  for	  the	  pCO2	  to	  rise	  by	  
20	  mm	  Hg.	  This	  formula,	  however,	  does	  not	  apply	  to	  all	  patients.	  If	  the	  pCO2	  rises	  
more	  precipitously,	  acidosis	  may	  lead	  to	  hypotension	  and	  arrhythmias.	  Conversely,	  
if	  the	  pCO2	  rises	  slowly,	  the	  apnea	  test	  will	  be	  inconclusive	  and	  repeat	  testing	  would	  
be	  required.	  	  Alternative	  methods	  for	  monitoring	  pCO2	  rise,	  including	  end-­‐tidal	  
capnography,	  have	  led	  to	  better	  estimations	  of	  blood	  gas	  during	  the	  apneic	  period	  of	  
the	  tests.	  Exogenous	  administration	  of	  CO2	  has	  also	  been	  shown	  to	  be	  a	  safe	  method,	  
though	  this	  technique	  is	  not	  currently	  standard	  practice	  (21).	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Ancillary	  Testing	  
If	  uncertainty	  exists	  about	  a	  part	  of	  the	  neurologic	  examination,	  or	  if	  the	  
apnea	  test	  cannot	  be	  performed,	  it	  is	  acceptable	  to	  use	  one	  of	  many	  ancillary	  tests	  to	  
confirm	  the	  diagnosis.	  These	  confirmatory	  tests	  are	  not	  mandatory	  in	  the	  United	  
States	  and	  are	  only	  used	  during	  situations	  when	  uncertainty	  exists.	  In	  many	  
countries,	  confirmatory	  tests	  are	  mandatory	  (22).	  Ancillary	  tests	  are	  employed	  to	  
demonstrate	  loss	  of	  bioelectrical	  activity	  of	  the	  brain	  or	  to	  confirm	  cerebral	  
circulatory	  arrest	  (10).	  These	  tests	  include	  cerebral	  angiography,	  transcranial	  
Doppler	  ultrasonography	  (TCD),	  radionuclide	  scintigraphy,	  EEG,	  CT	  angiography	  
(CTA),	  and	  MR	  angiography	  (MRA)	  (although	  the	  latter	  two	  are	  not	  validated	  nor	  
recommended).	  	  
Cerebral	  angiography	  involves	  injection	  of	  contrast	  medium	  at	  high	  pressure	  
into	  the	  aortic	  arch	  in	  order	  to	  allow	  entry	  into	  the	  anterior	  and	  posterior	  
circulations.	  In	  brain	  death,	  no	  intracerebral	  filling	  via	  the	  carotid	  or	  vertebral	  
arteries	  should	  be	  detected.	  TCD	  should	  show	  either	  reverberating	  flow	  or	  small	  
peaks	  in	  early	  systole,	  and	  there	  should	  be	  bilateral	  and	  anterior/posterior	  
insonation	  with	  the	  probe	  placed	  over	  the	  temporal	  bone.	  A	  finding	  of	  absence	  of	  
flow	  is	  not	  reliable,	  as	  this	  could	  be	  a	  reflection	  of	  inadequate	  bone	  windows.	  
Cerebral	  scintigraphy	  should	  show	  no	  radionuclide	  localization	  in	  the	  anterior	  
cerebral	  artery,	  middle	  cerebral	  artery,	  or	  basilar	  artery	  territories.	  Only	  minimal	  
tracer	  may	  be	  seen	  in	  the	  superior	  sagittal	  sinus,	  since	  some	  tracer	  may	  drain	  there	  
from	  scalp	  blood	  vessels.	  CTA	  is	  not	  currently	  a	  preferred	  ancillary	  test	  for	  
confirming	  brain	  death,	  given	  studies	  showing	  high	  false-­‐negative	  rates	  (23)	  as	  well	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as	  case	  reports	  of	  false-­‐positives	  (24).	  EEG	  should	  confirm	  a	  lack	  of	  reactivity	  to	  
intense	  somatosensory	  or	  audiovisual	  stimuli.	  
The	  use	  of	  ancillary	  testing	  to	  support	  brain	  death	  is	  not	  universally	  
accepted.	  In	  recent	  years,	  there	  have	  been	  arguments	  by	  Wijdicks	  (22)	  and	  others	  
against	  the	  use	  of	  ancillary	  tests	  as	  “confirmatory”	  tests.	  In	  a	  2010	  review,	  Wijdicks	  
emphasized	  that	  brain	  death	  is	  a	  clinical	  state	  with	  no	  prototypical	  neuropathologic	  
findings.	  If	  no	  such	  findings	  exist,	  then	  what	  are	  we	  testing	  for	  with	  ancillary	  tests?	  
He	  also	  argued	  that	  these	  tests	  are	  costly,	  and	  false	  positives	  and	  negatives	  can	  (and	  
often	  do)	  result	  in	  confusion	  and	  delays	  in	  the	  organ	  donation	  process.	  Nevertheless,	  
many	  countries	  around	  the	  world	  continue	  to	  require	  these	  tests	  to	  be	  performed	  
(25)	  and	  clinicians	  in	  the	  United	  States	  frequently	  elect	  to	  perform	  them	  (14).	  	  
	  The	  authors	  of	  the	  most	  recent	  AAN	  practice	  parameters	  caution	  against	  
using	  ancillary	  tests	  in	  lieu	  of	  critical	  components	  of	  the	  neurologic	  exam.	  Indeed,	  




Variability	  of	  Guidelines	  	  
Despite	  the	  publication	  of	  AAN	  practice	  parameters	  for	  the	  determination	  of	  
brain	  death,	  the	  ambiguity	  of	  the	  UDDA	  	  –	  originally	  intended	  to	  take	  into	  account	  
future	  advancements	  in	  diagnostic	  techniques	  –	  allowed	  for	  significant	  variation	  in	  
protocols	  for	  brain	  death	  determination	  among	  hospitals,	  between	  states,	  and	  
internationally.	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In	  2008,	  Greer	  et	  al.	  (26)	  evaluated	  differences	  in	  brain	  death	  guidelines	  
among	  leading	  U.S.	  hospitals,	  and	  found	  that	  many	  centers	  did	  not	  adhere	  to	  the	  
AAN	  practice	  parameters	  with	  respect	  to	  the	  clinical	  examination,	  apnea	  testing	  and	  
ancillary	  tests.	  Institutions	  varied	  widely	  with	  regard	  to	  who	  could	  perform	  brain	  
death	  determination:	  a	  neurologist	  or	  neurosurgeon	  was	  required	  to	  be	  involved	  in	  
only	  42%	  of	  guidelines,	  and	  of	  these,	  only	  35%	  required	  that	  an	  attending	  physician	  
be	  involved.	  There	  was	  poor	  compliance	  with	  the	  prerequisites	  specified	  in	  the	  
practice	  parameters,	  most	  notably	  in	  establishing	  a	  cause	  (63%),	  as	  well	  as	  in	  
ensuring	  absence	  of	  sedatives	  and	  paralytics	  (55%),	  acid-­‐base	  disorders	  (45%),	  and	  
endocrine	  disorders	  (42%).	  Widely	  disparate	  minimum	  temperatures	  were	  
mentioned,	  with	  80%	  of	  guidelines	  specifying	  temperatures	  colder	  than	  the	  
minimum	  recommended	  temperature.	  The	  prerequisite	  blood	  pressure	  to	  begin	  the	  
examination	  was	  also	  variable,	  and	  24%	  of	  guidelines	  did	  not	  specify	  a	  value.	  Only	  
55%	  of	  protocols	  specified	  using	  supplementary	  oxygen	  during	  the	  apnea	  test,	  and	  
only	  66%	  required	  that	  an	  ABG	  be	  drawn	  before	  the	  test.	  	  
A	  study	  by	  Wijdicks	  in	  2002	  (25)	  examined	  variability	  in	  brain	  death	  
guidelines	  across	  80	  different	  countries	  and	  found	  that	  there	  is	  also	  considerable	  
international	  variability	  in	  brain	  death	  criteria.	  Most	  striking	  was	  the	  omission	  of	  
the	  apnea	  test	  in	  41%	  of	  the	  surveyed	  countries.	  Countries	  also	  differed	  in	  the	  
number	  of	  physicians	  required	  to	  declare	  brain	  death	  and	  the	  expertise	  of	  the	  
examining	  physicians.	  A	  study	  by	  Citerio	  et	  al.	  in	  2014	  (27)	  confirmed	  the	  
persistence	  of	  widely	  disparate	  brain	  death	  criteria	  among	  countries	  in	  Europe.	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Variability	  of	  Practice	  
In	  2013,	  Shappell	  et	  al.	  (14)	  reviewed	  the	  charts	  of	  all	  adult	  brain	  dead	  organ	  
donors	  during	  2011	  from	  68	  hospitals	  in	  the	  Midwestern	  United	  States,	  and	  found	  
that	  documentation	  of	  brain	  death	  determination	  was	  often	  deficient,	  and	  did	  not	  
reflect	  strict	  adherence	  to	  the	  AAN	  practice	  parameters.	  There	  was	  documentation	  
of	  abnormal	  sodium	  levels	  in	  two	  thirds	  of	  the	  subjects,	  and	  15.5%	  had	  a	  core	  body	  
temperature	  lower	  than	  36°C.	  Testing	  of	  brainstem	  reflexes	  and	  response	  to	  noxious	  
stimulation	  was	  documented	  completely	  in	  45.1%	  of	  patients.	  Apnea	  testing	  was	  not	  
completed	  in	  20.8%	  of	  cases,	  and	  of	  these,	  93.3%	  had	  ancillary	  testing	  consistent	  
with	  brain	  death.	  Overall,	  44.7%	  adhered	  strictly,	  37.2%	  adhered	  loosely,	  and	  18.1%	  
received	  a	  designation	  of	  “incomplete.”	  This	  study	  was	  the	  first	  to	  examine	  brain	  
death	  determination	  in	  actual	  practice.	  The	  authors	  emphasized	  that	  the	  observed	  
variability	  in	  documentation,	  while	  highly	  concerning	  and	  certainly	  unacceptable,	  
does	  not	  necessarily	  reflect	  practice.	  	  
The	  study	  by	  Shappell	  et	  al.	  provided	  a	  valuable	  snapshot	  of	  the	  state	  of	  
documentation	  of	  brain	  death	  determination.	  This	  is	  an	  important	  first	  step	  in	  
ensuring	  proper	  practice	  in	  determining	  brain	  death;	  however,	  no	  study	  to	  date	  has	  
directly	  evaluated	  the	  clinical	  competence	  of	  physicians	  determining	  brain	  death.	  It	  
is	  well	  known	  that	  the	  neurologic	  examination	  requires	  special	  expertise.	  For	  
example,	  the	  differentiation	  of	  spinally-­‐mediated	  reflexes	  from	  retained	  motor	  
responses	  associated	  with	  brain	  activity	  is	  difficult	  for	  any	  non-­‐neurologist	  without	  
special	  training.	  Similarly,	  the	  apnea	  test	  requires	  that	  the	  operator	  be	  adept	  in	  
prevention	  and	  management	  of	  potential	  complications.	  If	  practice	  is	  consistent	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with	  knowledge,	  the	  studies	  mentioned	  above	  suggest	  that	  there	  is	  a	  striking	  
knowledge	  gap	  in	  this	  area—one	  that	  has	  yet	  to	  be	  assessed	  directly	  or	  addressed	  
effectively.	  This	  deficiency	  of	  knowledge	  in	  such	  a	  clinically	  important,	  legally	  
complicated,	  and	  emotionally	  charged	  area	  led	  us	  to	  develop	  a	  training	  course	  in	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Statement	  of	  Purpose	  
We	  created	  a	  two-­‐part	  brain	  death	  determination	  training	  course	  –	  with	  both	  
didactic	  and	  simulation	  sessions	  –	  in	  order	  to	  achieve	  the	  following	  goals.	  First,	  we	  
wanted	  to	  determine	  baseline	  knowledge	  of	  brain	  death	  concepts	  among	  physicians	  
at	  varying	  levels	  of	  training	  and	  across	  different	  specialties	  at	  Yale-­‐New	  Haven	  
Hospital.	  Second,	  we	  wanted	  to	  evaluate	  the	  clinical	  competence	  of	  these	  physicians	  
in	  performing	  the	  brain	  death	  examination	  under	  varied	  circumstances.	  Finally,	  we	  
sought	  to	  instruct	  physicians	  in	  the	  proper	  determination	  of	  brain	  death	  via	  a	  
didactic	  lecture,	  video	  demonstration,	  and	  simulation	  exercise.	  A	  long-­‐term	  aim	  of	  
our	  work	  was	  to	  use	  the	  experience	  of	  running	  the	  course	  and	  refining	  our	  process	  
within	  our	  home	  institution	  to	  create	  a	  replicable	  training	  course	  that	  could	  be	  
implemented	  at	  institutions	  across	  the	  country.	  
Based	  on	  our	  own	  experience	  and	  studies	  that	  had	  emerged	  highlighting	  
variability	  of	  practice,	  we	  hypothesized	  that	  baseline	  knowledge	  of	  brain	  death	  
determination	  among	  providers	  would	  be	  low.	  However,	  we	  anticipated	  that	  
knowledge	  of	  brain	  death	  concepts	  and	  clinical	  competence	  in	  performing	  the	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Methods	  
Division	  of	  Responsibilities	  
Ben	  MacDougall:	  creation	  of	  the	  simulation	  scenario,	  script,	  and	  checklist;	  first	  assist	  
for	  ~1/3	  of	  the	  simulations;	  data	  collection	  and	  all	  statistical	  analysis;	  preparation	  
of	  manuscript.	  	  
David	  Greer:	  creation	  of	  the	  simulation	  scenario;	  creation	  of	  multiple-­‐choice	  test	  
questions;	  primary	  facilitator	  for	  all	  simulations;	  data	  collection;	  preparation	  of	  
manuscript.	  	  
Liana	  Kappus:	  creation	  of	  the	  simulation	  scenario;	  preparation	  of	  the	  simulation	  
environment.	  	  
Jennifer	  Robinson:	  first	  assist	  in	  many	  of	  the	  simulations.	  
Stephanie	  Sudikoff:	  creation	  of	  multiple-­‐choice	  test	  questions.	  	  
	  
Objective	  
We	  implemented	  a	  simulation-­‐based	  training	  course	  on	  brain	  death	  
determination	  based	  on	  the	  AAN	  practice	  parameters	  to	  address	  and	  assess	  
knowledge	  and	  practice	  gaps	  at	  our	  institution.	  The	  intervention	  consisted	  of	  a	  two-­‐
part	  training	  course:	  a	  didactic	  session	  and	  a	  scored	  simulation	  exercise,	  and	  was	  
bookended	  by	  before	  and	  after	  multiple-­‐choice	  tests	  to	  assess	  baseline	  and	  post-­‐




	   15	  
Evaluation	  
Knowledge	  was	  assessed	  using	  20-­‐question,	  multiple-­‐choice	  pre-­‐	  and	  post-­‐
tests.	  The	  pre-­‐test	  was	  given	  immediately	  before	  the	  didactic	  session	  to	  assess	  
baseline	  knowledge,	  and	  the	  post-­‐test	  was	  given	  immediately	  after	  the	  simulation	  to	  
assess	  the	  course’s	  efficacy	  in	  improving	  knowledge.	  The	  participants	  were	  not	  
notified	  of	  the	  pre-­‐test	  in	  advance	  since	  we	  sought	  an	  accurate	  assessment	  of	  
baseline	  knowledge.	  Questions	  formulated	  by	  experts	  at	  our	  institution	  were	  based	  
on	  the	  AAN	  practice	  parameters	  as	  well	  as	  common	  pitfalls	  described	  in	  the	  
literature.	  The	  questions	  were	  categorized	  based	  on	  the	  type	  of	  knowledge	  required	  
to	  test	  for	  specific	  areas	  of	  weakness.	  The	  categories	  were:	  general	  knowledge	  (4	  on	  
pre-­‐test,	  4	  on	  post-­‐test),	  clinical	  exam	  (4,	  4),	  apnea	  test	  (4,4),	  ancillary	  testing	  (3,2),	  
confounders	  (2,3),	  and	  prerequisites	  (3,	  3).	  	  
Simulation	  performance	  was	  evaluated	  according	  to	  a	  26-­‐point	  checklist	  
(figures	  2,3)	  that	  closely	  mirrors	  the	  checklist	  provided	  in	  the	  AAN	  practice	  
parameters.	  In	  addition	  to	  completion	  of	  a	  standard	  brain	  death	  examination,	  points	  
were	  awarded	  for	  recognizing	  and	  responding	  to	  several	  embedded	  confounders	  
and	  signs,	  and	  for	  ensuring	  that	  prerequisite	  requirements	  were	  met	  prior	  to	  the	  
examination,	  as	  described	  below.	  	  	  
	  
Didactic	  
The	  didactic	  session	  covered	  the	  following	  aspects	  of	  brain	  death	  
determination:	  1)	  historical	  context	  and	  definition,	  2)	  clinical	  examination,	  3)	  apnea	  
testing,	  4)	  ancillary	  testing,	  5)	  confounders	  and	  6)	  common	  pitfalls.	  David	  Greer,	  a	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neurologist	  and	  brain	  death	  expert	  at	  our	  institution,	  gave	  all	  didactics.	  To	  illustrate	  
the	  technical	  aspects	  of	  the	  examination,	  a	  proper	  brain	  death	  examination	  video	  
was	  shown.	  	  
	  
Simulation	  
We	  chose	  a	  simulation-­‐based	  approach	  given	  its	  superiority	  over	  traditional	  
medical	  education	  techniques	  in	  achieving	  specific	  clinical	  skills	  goals	  (28).	  
	  
Preparation	  and	  Equipment	  
We	  utilized	  the	  SimMan	  3G	  simulation	  manikin	  (SimMan	  3G®,	  Laerdal	  
Medical,	  Wappingers	  Falls,	  NY).	  This	  model	  was	  selected	  for	  its	  pupil	  reactivity	  and	  
seizure	  functionalities,	  both	  used	  in	  our	  scenario.	  We	  adapted	  the	  manikin	  with	  an	  
on-­‐layed	  earpiece	  that	  allowed	  for	  injection	  of	  water	  into	  the	  ear	  canal	  to	  assess	  the	  
oculovestibular	  reflex	  without	  compromising	  the	  electronics.	  The	  manikin	  was	  
intubated	  with	  a	  7.0	  mm	  cuffed	  endotracheal	  tube	  with	  an	  in-­‐line	  suction	  catheter	  in	  
place.	  	  The	  monitor	  displayed	  heart	  rate,	  oxygen	  saturation,	  blood	  pressure,	  
temperature,	  respiratory	  rate	  and	  end	  tidal	  CO2.	  	  	  
We	  provided	  ice	  water	  and	  a	  60	  cc	  syringe	  with	  tubing	  to	  assess	  the	  
oculovestibular	  reflex	  (OVR);	  cotton	  swabs	  for	  corneal	  reflex	  testing;	  a	  reflex	  
hammer	  to	  assess	  deep	  tendon	  reflexes,	  plantar	  response,	  and	  responsiveness	  to	  
noxious	  stimuli;	  a	  flashlight	  for	  pupillary	  assessment;	  and	  a	  suction	  catheter	  and	  
oxygen	  tubing	  for	  the	  apnea	  test.	  The	  scenario	  was	  scripted	  and	  programmed	  using	  
Laerdal	  SimMan	  3G	  software	  and	  progressed	  based	  on	  the	  participant	  performing	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critical	  actions	  and/or	  the	  facilitator	  offering	  cues	  to	  move	  forward	  within	  the	  
simulation.	  	  	  
	  
Staff	  
A	  simulation	  technician	  prepared	  the	  environment	  and	  controlled	  the	  
simulator	  from	  a	  control	  room.	  The	  facilitator,	  a	  senior	  neurologist	  versed	  in	  brain	  
death,	  conducted	  the	  session,	  including	  the	  orientation,	  simulation,	  and	  debriefing.	  
We	  also	  invited	  nurses	  and	  mid-­‐level	  providers	  from	  our	  neuro	  ICU	  to	  assist	  with	  
the	  simulation	  and	  debriefing	  exercises.	  Facilitators	  were	  required	  to	  participate	  in	  
an	  8-­‐hour	  faculty	  development	  course	  run	  by	  our	  institution’s	  simulation	  center	  
(SYN:APSE	  Center	  for	  Learning,	  Transformation	  and	  Innovation).	  	  
	  
Orientation	  and	  Initial	  Prompt	  
Participants	  were	  read	  a	  scripted	  orientation	  to	  the	  simulator’s	  capabilities	  
and	  limitations,	  the	  environment	  and	  equipment,	  and	  the	  process	  and	  expectations	  
for	  the	  session	  (figure	  1).	  The	  facilitator	  provided	  a	  scenario	  of	  a	  54-­‐year-­‐old	  man	  
who	  suffered	  a	  prolonged	  cardiac	  arrest	  48	  hours	  earlier,	  not	  treated	  with	  
therapeutic	  hypothermia.	  Vital	  signs,	  oxygen	  saturation,	  ventilator	  settings,	  as	  well	  
as	  recent	  chest	  x-­‐ray,	  head	  computed	  tomography	  results	  and	  arterial	  blood	  gas	  
(ABG)	  values	  were	  provided.	  We	  immediately	  provided	  information	  ruling	  out	  
several	  confounders,	  rather	  than	  having	  the	  participant	  seek	  this	  information	  
independently,	  including	  the	  absence	  of	  paralytics,	  prior	  therapeutic	  hypothermia,	  
sedating	  medications,	  cervical	  spine	  injury,	  hyperammonemia,	  or	  significant	  acid-­‐
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base,	  endocrine	  or	  electrolyte	  disorders.	  In	  practice,	  eliminating	  these	  confounders	  
is	  obviously	  of	  critical	  importance.	  However,	  we	  eliminated	  them	  to	  save	  time	  so	  
that	  the	  simulation	  could	  be	  spent	  practicing	  the	  technical	  aspects	  of	  the	  clinical	  
exam	  and	  apnea	  test,	  which	  lent	  themselves	  more	  to	  simulation-­‐based	  learning.	  	  
Participants	  were	  told	  to	  perform	  a	  complete	  brain	  death	  exam,	  including	  an	  
apnea	  test.	  They	  were	  informed	  that	  the	  facilitator	  was	  to	  function	  as	  nurse	  and	  
respiratory	  therapist,	  that	  time	  was	  adjusted	  for	  the	  purposes	  of	  the	  exercise	  (for	  
example,	  the	  facilitator	  could	  state	  that	  24	  hours	  had	  passed	  since	  a	  change	  was	  
requested,	  rather	  than	  having	  to	  wait	  for	  the	  effects	  of	  a	  change),	  and	  that	  the	  
patient	  might	  not	  be	  brain	  dead	  on	  initial	  evaluation.	  They	  were	  asked	  to	  verbalize	  
their	  examination	  and	  thought	  process.	  	  
	  
The	  Clinical	  Exam	  
Participants	  were	  allowed	  to	  complete	  the	  examination	  in	  whatever	  order	  
they	  preferred,	  although	  the	  apnea	  test	  was	  to	  be	  performed	  last.	  A	  checklist	  
adapted	  from	  the	  most	  recent	  AAN	  guidelines	  was	  used	  to	  track	  and	  evaluate	  
performance	  (figure	  2).	  If	  a	  participant	  omitted	  a	  component	  of	  the	  clinical	  exam,	  we	  
did	  not	  notify	  them	  until	  after	  the	  exercise	  was	  completed.	  	  
The	  manikin	  was	  fully	  covered	  with	  a	  sheet.	  The	  physician	  was	  expected	  to	  
uncover	  the	  extremities	  (maintaining	  decency	  on	  the	  manikin)	  to	  facilitate	  
observation	  of	  any	  movement	  in	  response	  to	  stimulation.	  There	  were	  three	  findings	  
on	  the	  examination	  that	  prevented	  the	  initial	  declaration	  of	  brain	  death.	  The	  first	  
was	  communicated	  in	  the	  initial	  prompt—the	  patient’s	  temperature	  was	  34°C,	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requiring	  warming	  to	  achieve	  at	  least	  36°C.	  The	  second	  was	  recognition	  that	  the	  
patient	  was	  having	  a	  seizure,	  manifested	  by	  spontaneous	  vigorous	  clonic	  activity	  of	  
the	  manikin	  one	  minute	  into	  the	  exercise.	  If	  the	  physician	  correctly	  recognized	  that	  
a	  seizure	  is	  incompatible	  with	  a	  determination	  of	  brain	  death,	  we	  then	  instructed	  
that	  that	  one	  day	  had	  passed	  without	  any	  further	  witnessed	  seizures.	  The	  last	  
incompatible	  finding	  was	  a	  reactive	  pupil.	  If	  the	  examiner	  correctly	  chose	  to	  stop	  the	  
examination,	  we	  would	  indicate	  that	  one	  day	  had	  passed	  with	  no	  further	  evidence	  of	  
pupillary	  reactivity.	  Upon	  further	  examination,	  the	  pupil	  would	  no	  longer	  react.	  The	  
remainder	  of	  the	  clinical	  examination	  was	  consistent	  with	  a	  clinical	  diagnosis	  of	  
brain	  death.	  The	  expected	  components	  of	  a	  complete	  examination,	  along	  with	  their	  
associated	  findings,	  are	  outlined	  in	  the	  script	  (figure	  2).	  	  
With	  completion	  of	  the	  clinical	  examination,	  we	  provided	  an	  additional	  
prompt:	  the	  urine	  bag	  was	  filling	  rapidly,	  implicating	  possible	  central	  diabetes	  
insipidus.	  The	  correct	  response	  was	  to	  give	  intravenous	  fluids	  and/or	  DDAVP	  to	  
correct	  hypovolemia.	  If	  the	  participant	  did	  not	  respond	  appropriately,	  we	  explained	  
the	  correct	  response	  to	  ensure	  that	  they	  could	  move	  forward	  with	  apnea	  testing.	  	  
	  
The	  Apnea	  Test	  
The	  script	  and	  evaluation	  checklist	  for	  the	  apnea	  test	  (figure	  3)	  were	  also	  
adapted	  from	  the	  AAN	  practice	  parameters.	  The	  facilitator	  began	  by	  reorienting	  the	  
participant	  with	  the	  most	  recent	  ventilator	  settings,	  blood	  pressure	  and	  ABG	  values.	  
The	  ABG	  reflected	  any	  changes	  in	  minute	  ventilation	  or	  FiO2	  the	  participant	  may	  
have	  made	  earlier,	  such	  as	  pre-­‐oxygenation	  or	  establishing	  normocarbia.	  The	  initial	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ABG	  values	  were	  pH	  7.54,	  pCO2	  30	  mm	  Hg,	  and	  pO2	  110	  mm	  Hg	  (henceforth	  
abbreviated	  as	  pH/pCO2/pO2),	  with	  the	  ventilator	  set	  on	  assist	  control	  ventilation	  
(respiratory	  rate	  20/minute,	  tidal	  volume	  750	  mL,	  FiO2	  50%,	  PEEP	  5	  cm	  H2O).	  The	  
facilitator	  asked	  the	  participant	  if	  they	  wished	  to	  modify	  the	  ventilator	  settings	  
before	  the	  apnea	  test.	  We	  listed	  three	  potential	  ABG	  values	  in	  the	  script	  based	  on	  
these	  modifications	  (figure	  1).	  	  If	  the	  participant	  chose	  to	  decrease	  the	  minute	  
ventilation,	  the	  ABG	  would	  be	  7.38/42/90,	  and	  if	  they	  also	  chose	  to	  increase	  the	  
FiO2	  to	  100%	  the	  ABG	  would	  be	  7.38/42/270.	  The	  appropriate	  action	  was	  to	  
decrease	  the	  minute	  ventilation	  via	  respiratory	  rate	  and/or	  tidal	  volume	  reduction,	  
and	  to	  increase	  the	  FiO2	  to	  100%	  for	  pre-­‐oxygenation.	  	  
At	  the	  equivalent	  of	  three	  minutes	  into	  the	  apnea	  test,	  the	  participant	  was	  
informed	  that	  the	  blood	  pressure	  was	  slightly	  lower	  (but	  still	  within	  an	  acceptable	  
range);	  no	  action	  was	  warranted.	  At	  the	  equivalent	  of	  six	  minutes	  into	  the	  apnea	  
test,	  the	  participant	  was	  notified	  that	  the	  patient’s	  blood	  pressure	  had	  dropped	  to	  
98/50	  mmHg.	  The	  correct	  response	  was	  not	  to	  terminate	  the	  exam,	  but	  rather	  to	  
administer	  a	  vasopressor	  or	  fluid	  bolus,	  which	  results	  in	  correction	  of	  the	  blood	  
pressure	  to	  an	  acceptable	  level.	  At	  the	  equivalent	  of	  ten	  minutes	  into	  the	  apnea	  test,	  
the	  participant	  was	  notified	  that	  10	  minutes	  had	  passed	  and	  that	  the	  patient’s	  pulse	  
oximetry	  reading	  was	  88%.	  This	  reading	  is	  within	  the	  acceptable	  range,	  and	  the	  
correct	  response	  was	  to	  ask	  for	  an	  ABG	  and	  reconnect	  the	  ventilator.	  The	  final	  ABG	  
result	  was	  7.10/66/65,	  and	  the	  participant	  was	  expected	  to	  declare	  brain	  death.	  	  
Unlike	  during	  the	  clinical	  examination,	  the	  facilitator	  guided	  the	  participants	  
through	  the	  apnea	  test	  if	  they	  were	  unsure	  of	  the	  next	  step	  to	  ensure	  that	  every	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participant	  had	  the	  experience	  of	  conducting	  a	  full	  apnea	  test.	  Furthermore,	  in	  the	  
context	  of	  a	  simulation	  exercise,	  anticipating	  and	  realistically	  simulating	  the	  results	  
of	  an	  incorrectly	  conducted	  apnea	  test	  was	  tedious	  and	  of	  little	  educational	  value,	  
since	  the	  results	  of	  an	  apnea	  test	  are	  only	  meaningful	  if	  conducted	  according	  to	  
established	  guidelines.	  In	  addition,	  the	  physiological	  models	  that	  the	  simulator	  
employs	  are	  not	  sophisticated	  enough	  to	  account	  for	  the	  heterogeneous	  
constellations	  of	  disturbances	  that	  often	  occur	  in	  patients	  that	  have	  suffered	  severe	  
neurological	  damage.	  For	  these	  reasons,	  we	  chose	  to	  only	  offer	  three	  possible	  ABG	  
values	  based	  on	  the	  correct	  changes	  in	  the	  ventilator	  settings	  (i.e.	  decreasing	  minute	  
ventilation,	  increasing	  FiO2	  to	  100%,	  or	  both).	  	  
	  
Debriefing	  	  
Following	  the	  simulation,	  the	  participant	  and	  facilitator	  debriefed.	  The	  
structure	  of	  this	  session	  was	  based	  on	  the	  3-­‐phased	  approach	  prominent	  in	  
simulation	  literature.	  This	  approach	  includes:	  1)	  a	  description	  phase	  during	  which	  
participants	  offer	  initial	  reactions	  and	  their	  understanding	  of	  the	  clinical	  facts	  of	  the	  
case;	  2)	  an	  analysis	  phase	  during	  which	  the	  facilitator	  and	  participant	  discussed	  
performance	  gaps;	  and	  3)	  a	  synthesis	  phase	  during	  which	  the	  facilitator	  and	  
participant	  summarized	  key	  take	  home	  points	  to	  apply	  to	  clinical	  practice	  (29-­‐31).	  
The	  checklist	  was	  used	  during	  the	  analysis	  phase	  to	  provide	  specific	  feedback	  on	  
performance.	  Participants	  also	  had	  the	  opportunity	  to	  return	  to	  the	  mannequin	  to	  
practice	  challenging	  techniques.	  Subsequent	  to	  the	  debriefing,	  participants	  
	   22	  
completed	  an	  evaluation	  of	  the	  session	  and	  facilitator	  for	  quality	  improvement	  
purposes.	  They	  then	  completed	  the	  20-­‐question	  post-­‐test.	  	  
	  	  
Statistical	  Analysis	  
Test	  and	  simulation	  scores	  between	  groups	  were	  compared	  using	  Student’s	  
t-­‐test	  for	  continuous	  variables.	  Statistical	  significance	  was	  established	  at	  p	  <0.05	  (2-­‐
tailed).	  Comparisons	  were	  made	  between	  pre-­‐course,	  post-­‐course	  and	  simulation	  
scores	  across	  different	  specialties	  and	  different	  levels	  of	  training.	  The	  Pearson	  
product-­‐moment	  correlation	  coefficient	  was	  calculated	  based	  on	  matched	  pre-­‐test	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Results	  
111	  clinicians	  participated	  in	  the	  course	  (table	  1),	  38	  of	  whom	  completed	  the	  
simulation.	  Our	  highest	  participation	  rates	  came	  from	  neurology	  attendings	  (17/32	  
practicing	  faculty),	  trauma	  and	  surgical	  critical	  care	  attendings	  (10/11	  practicing	  
faculty),	  neurology	  residents	  (19/23	  from	  PGY2-­‐4),	  neurosurgery	  residents	  (9/14	  
from	  PGY1-­‐7),	  and	  emergency	  medicine	  residents	  (13/38	  from	  PGY2-­‐4).	  	  
Participants	  scored	  an	  average	  of	  43.1%	  (n=111)	  on	  the	  pre-­‐course	  test.	  
Overall,	  pre-­‐test	  scores	  (figure	  4)	  were	  higher	  among	  attendings	  (n=	  51)	  than	  
residents	  (n=	  42),	  with	  scores	  of	  49.0%	  vs.	  40.4%,	  respectively	  (p=	  0.008).	  There	  
was	  also	  a	  positive	  trend	  among	  residents	  between	  post-­‐graduate	  years	  (PGY)	  1	  and	  
4,	  with	  residents	  scoring	  incrementally	  higher	  in	  each	  successive	  year	  (figure	  5).	  
Residents	  in	  PGY5	  and	  above,	  however,	  did	  not	  follow	  the	  same	  trend.	  Among	  
physicians	  in	  neurology	  and	  neurosurgery,	  attendings	  scored	  significantly	  higher	  
than	  residents	  (54.7%	  vs.	  42.1%,	  p=	  0.002).	  	  Attendings	  in	  neurology	  and	  
neurosurgery	  scored	  significantly	  higher	  than	  those	  in	  other	  specialties	  (54.7%	  vs.	  
41.0%,	  p=	  0.002).	  	  Similarly,	  residents	  in	  neurology	  and	  neurosurgery	  outperformed	  
other	  residents,	  though	  the	  margin	  was	  not	  significant	  (42.1%	  vs.	  37.1%,	  p=	  0.24).	  
Interestingly,	  pre-­‐test	  scores	  among	  the	  38	  participants	  who	  have	  completed	  the	  
entire	  course	  were	  significantly	  higher	  than	  the	  52	  who	  have	  had	  the	  opportunity	  to	  
complete	  the	  simulation	  but	  have	  not	  yet	  done	  so	  (45.3%	  vs.	  38.6%,	  p=	  0.04).	  	  
Simulation	  performance	  (figure	  6)	  was	  weakly	  correlated	  (r=0.30)	  with	  pre-­‐
test	  scores.	  The	  mean	  simulation	  score	  among	  all	  providers	  was	  67.2%	  (n=	  38).	  
There	  were	  no	  significant	  differences	  in	  simulation	  performance	  based	  on	  specialty	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or	  level	  of	  training.	  Attendings	  (n=21)	  scored	  higher	  than	  residents	  (n=15)	  on	  the	  
26-­‐point	  evaluation	  (72.2%	  vs.	  64.4%,	  p	  =	  0.15),	  and	  physicians	  in	  neurology	  and	  
neurosurgery	  scored	  higher	  than	  those	  in	  other	  fields	  (69.8%	  vs.	  65.7%,	  p	  =	  0.47).	  
Common	  omissions	  (figure	  7)	  included:	  uncovering	  the	  extremities	  during	  the	  
clinical	  exam	  (79%	  omitted),	  uncovering	  the	  chest	  and	  abdomen	  during	  the	  apnea	  
test	  (79%	  omitted),	  and	  testing	  for	  blinking	  to	  visual	  threat	  (76%	  omitted).	  Areas	  of	  
strength	  (figure	  8)	  included:	  testing	  the	  oculocephalic	  reflex	  (95%	  performed),	  
decreasing	  the	  minute	  ventilation	  on	  the	  ventilator	  to	  achieve	  normocarbia	  prior	  to	  
the	  apnea	  test	  (82%	  performed),	  detaching	  the	  ventilator	  and	  providing	  O2	  via	  
suction	  catheter	  to	  begin	  the	  apnea	  test	  (84%	  performed),	  asking	  for	  a	  repeat	  ABG	  
and	  the	  end	  of	  the	  apnea	  test	  (89%	  performed),	  and	  correctly	  declaring	  brain	  death	  
(87%	  performed).	  	  
The	  simulation	  cohort’s	  post-­‐test	  scores	  were	  significantly	  higher	  than	  their	  
pre-­‐test	  scores	  (figure	  9),	  improving	  from	  a	  mean	  of	  45.4%	  to	  a	  mean	  of	  73.3%	  
(p<0.001).	  Participants	  improved	  significantly	  in	  all	  categories,	  with	  the	  exception	  
of	  ancillary	  testing,	  where	  there	  was	  a	  non-­‐significant	  decrease	  in	  scores.	  	  
On	  the	  post-­‐course	  feedback	  form,	  participants	  gave	  the	  course	  an	  average	  
rating	  of	  “excellent,”	  and	  selected	  “strongly	  agree”	  in	  response	  to	  the	  statements	  
“the	  course	  was	  realistic,”	  “I	  was	  able	  to	  practice	  skills	  I	  often	  don’t	  get	  to	  practice,”	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Discussion	  	  
Herein	  we	  describe	  a	  didactic	  and	  simulation-­‐based	  intervention	  for	  
caregivers	  to	  increase	  competence	  in	  clinical	  brain	  death	  determination.	  The	  
necessity	  of	  this	  intervention	  was	  evidenced	  by	  participants	  scoring	  an	  average	  of	  
43.1%	  (n=111)	  on	  the	  pre-­‐course	  test,	  and	  67.2%	  (n=	  38)	  on	  the	  simulation,	  which	  
evaluated	  fundamental	  knowledge	  and	  clinical	  skills	  required	  to	  perform	  an	  
accurate	  brain	  death	  examination.	  These	  results	  are	  even	  more	  striking	  considering	  
that	  the	  majority	  of	  these	  physicians	  were	  specialists	  in	  fields	  in	  which	  the	  brain	  
death	  examination	  features	  prominently.	  Overall,	  the	  success	  of	  our	  intervention	  is	  
evidenced	  by	  a	  27.9%	  (n=38)	  absolute	  improvement	  in	  mean	  score	  from	  pre-­‐test	  to	  
post-­‐test,	  and	  by	  the	  uniformly	  positive	  feedback	  we	  received	  from	  our	  participants,	  
who	  routinely	  emphasized	  the	  importance	  and	  utility	  of	  training	  in	  brain	  death	  
determination.	  	  
Based	  on	  pre-­‐course	  tests,	  attendings	  in	  neurology	  and	  neurosurgery	  are	  
more	  familiar	  with	  brain	  death	  concepts	  and	  guidelines	  than	  specialists	  in	  other	  
fields	  commonly	  involved	  in	  brain	  death	  determination.	  This	  finding	  is	  particularly	  
important	  when	  considering	  that	  most	  brain	  death	  examinations	  are	  not	  performed	  
by	  neurologists	  or	  neurosurgeons	  (14),	  and	  that	  many	  leading	  U.S.	  hospitals’	  
guidelines	  do	  not	  require	  these	  specialists	  to	  perform	  the	  examination,	  or	  to	  be	  
involved	  at	  any	  point	  during	  the	  process	  (26).	  Level	  of	  training	  also	  seems	  to	  play	  an	  
important	  role:	  despite	  scoring	  higher	  than	  residents	  in	  other	  specialties,	  neurology	  
and	  neurosurgery	  residents	  scored	  significantly	  lower	  than	  attending	  physicians	  in	  
their	  field.	  This	  is	  not	  reflected	  in	  hospital	  policies:	  among	  the	  above-­‐mentioned	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hospitals	  that	  require	  a	  neurologist	  or	  neurosurgeon	  to	  perform	  the	  brain	  death	  
examination,	  the	  majority	  do	  not	  specify	  that	  this	  must	  be	  an	  attending	  physician	  
(26).	  Furthermore,	  in	  our	  study	  population,	  knowledge	  of	  brain	  death	  concepts	  
among	  residents	  increased	  with	  each	  post-­‐graduate	  year.	  The	  exception	  in	  our	  study	  
was	  the	  PGY5+	  cohort,	  which	  performed	  the	  poorest	  of	  all	  groups	  of	  residents.	  This	  
could	  be	  explained	  by	  the	  relatively	  small	  sample	  size	  of	  5	  PGY5+	  residents,	  and	  by	  
the	  fact	  that	  the	  neurology	  program	  –	  which	  represents	  the	  highest-­‐performing	  
group	  of	  residents	  –	  ends	  at	  PGY4.	  This	  trend	  suggests	  that	  residents	  themselves	  
cannot	  be	  viewed	  as	  a	  homogenous	  group	  in	  regard	  to	  clinical	  competence	  in	  brain	  
death	  determination.	  	  Again,	  we	  are	  not	  aware	  of	  any	  directives	  in	  hospital	  policies	  
that	  would	  suggest	  that	  this	  knowledge	  gap	  has	  been	  acknowledged.	  This	  is	  even	  
more	  remarkable	  when	  considering	  that	  only	  the	  top	  50	  U.S.	  News	  and	  World	  
Report-­‐ranked	  institutions	  were	  included	  in	  the	  Greer	  et	  al.	  study.	  Presumably,	  
these	  institutions	  have	  consistent	  access	  to	  attending	  neurologists	  and	  
neurosurgeons	  who	  could	  perform	  all	  brain	  death	  determinations.	  It	  is	  reasonable	  
to	  suggest	  that	  these	  physicians	  should	  be	  the	  preferred	  examiners	  in	  brain	  death	  
cases	  at	  hospitals	  with	  adequate	  staff,	  at	  least	  until	  a	  time	  that	  other	  practitioners	  
can	  be	  appropriately	  trained.	  	  
No	  group	  performed	  significantly	  better	  than	  another	  in	  the	  simulation	  
exercise,	  and	  simulation	  scores	  were	  weakly	  correlated	  (r=0.30)	  with	  pre-­‐test	  
scores.	  This	  lack	  of	  correlation	  could	  be	  due	  to	  a	  number	  of	  factors.	  Firstly,	  the	  pre-­‐
test	  was	  administered	  without	  warning,	  which	  likely	  provided	  a	  truer	  assessment	  of	  
baseline	  knowledge.	  Before	  the	  simulation,	  however,	  all	  participants	  benefited	  from	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the	  didactic	  session	  and	  significant	  time	  for	  preparation,	  which	  served	  to	  mitigate	  
this	  initial	  knowledge	  gap.	  It	  is	  also	  possible	  that	  physicians	  who	  did	  not	  have	  a	  
background	  in	  neurology	  or	  neurosurgery	  spent	  more	  time	  preparing	  for	  the	  
simulation,	  and	  that	  those	  with	  a	  neurology	  or	  neurosurgery	  background	  were	  
overconfident	  in	  their	  abilities.	  Finally,	  our	  ability	  to	  evaluate	  higher-­‐level	  technical	  
and	  observational	  skills,	  such	  as	  differentiating	  spinally-­‐mediated	  reflexes	  from	  
cerebrally-­‐mediated	  motor	  responses,	  was	  somewhat	  limited	  by	  the	  simulation	  
mannequin’s	  capabilities.	  It	  is	  possible	  that	  neurologists	  and	  neurosurgeons	  may	  
have	  scored	  higher	  if	  evaluated	  while	  performing	  the	  examination	  on	  a	  potentially	  
brain	  dead	  patient,	  where	  these	  skills	  can	  be	  more	  easily	  demonstrated	  and	  
evaluated.	  This	  setting,	  however,	  is	  not	  conducive	  to	  training	  and	  evaluating	  a	  large	  
group	  of	  physicians	  due	  to:	  1)	  the	  paucity	  of	  brain	  death	  examinations	  occurring	  at	  
our	  institution,	  and	  2)	  the	  time	  required	  to	  coordinate	  such	  a	  session.	  We	  feel	  that	  
the	  simulation	  mannequin	  allows	  trainees	  to	  benefit	  from	  an	  excellent	  hands-­‐on	  
experience	  without	  wasting	  time	  or	  institutional	  resources.	  An	  added	  benefit	  is	  that	  
we	  were	  able	  to	  standardize	  all	  signs	  and	  neurological	  exam	  findings	  for	  every	  
trainee	  to	  ensure	  uniformity	  across	  the	  study	  population.	  Additionally,	  for	  trainees	  
who	  wish	  to	  return	  for	  repeat	  simulation	  sessions,	  we	  are	  able	  to	  vary	  the	  signs	  and	  
findings	  to	  provide	  them	  with	  the	  broadest	  possible	  experience	  in	  a	  safe	  
environment.	  	  
Barriers	  to	  successful	  implementation	  of	  this	  strategy	  on	  a	  large	  scale	  –	  
including	  multi-­‐departmental	  cooperation	  and	  participation	  –	  are	  daunting.	  But	  our	  
experience	  speaks	  to	  the	  promise	  of	  our	  approach.	  Thus	  far,	  111	  clinicians	  have	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participated	  in	  the	  course.	  This,	  as	  shown	  above,	  represents	  a	  significant	  proportion	  
of	  the	  clinicians	  who	  could	  foreseeably	  be	  involved	  in	  a	  brain	  death	  determination	  at	  
Yale-­‐New	  Haven	  Hospital.	  Of	  these	  111	  participants,	  38	  have	  completed	  the	  
simulation	  component.	  Promisingly,	  Dr.	  Greer	  was	  recently	  able	  to	  implement	  a	  
similar	  simulation	  training	  course	  at	  a	  national	  conference	  (Neurocritical	  Care	  
Society)	  for	  20	  trainees,	  utilizing	  5	  other	  brain	  death	  experts	  and	  2	  SimMan	  
manikins.	  	  
A	  critical	  issue	  throughout	  the	  implementation	  of	  this	  training	  course	  was	  
that	  the	  number	  of	  completed	  simulations	  lags	  behind	  the	  number	  of	  didactic	  
attendees.	  This	  happened	  for	  several	  reasons.	  First,	  the	  didactic	  was	  usually	  
scheduled	  during	  a	  lecture	  slot	  requiring	  attendance,	  including	  grand	  rounds,	  noon	  
conference	  or	  special	  invited	  lectures	  to	  a	  specific	  group.	  However,	  simulation	  
required	  participants	  to	  schedule	  30-­‐minute	  sessions.	  Furthermore,	  the	  prospect	  of	  
being	  evaluated	  by	  a	  senior	  physician	  can	  be	  daunting,	  and	  it	  is	  possible	  that	  fear	  of	  
criticism	  −	  especially	  among	  those	  unfamiliar	  with	  the	  brain	  death	  exam	  −	  may	  have	  
led	  to	  avoidance	  of	  the	  simulation	  session,	  a	  point	  supported	  by	  significantly	  lower	  
pre-­‐test	  scores	  among	  those	  who	  did	  not	  sign	  up	  for	  the	  simulation.	  We	  have	  also	  
been	  limited	  by	  our	  ability	  to	  provide	  enough	  time	  slots	  for	  participants.	  At	  30	  
minutes	  per	  participant,	  it	  was	  unrealistic	  to	  train	  all	  111	  participants	  within	  a	  year.	  
This	  problem	  could	  be	  overcome	  by	  involving	  more	  instructors	  in	  the	  training	  
course.	  At	  our	  institution,	  a	  single	  physician	  administered	  the	  entire	  course,	  
including	  didactics	  and	  simulations,	  in	  order	  to	  ensure	  uniformity	  across	  the	  study	  
population.	  Implementing	  this	  course	  at	  other	  institutions	  would	  require	  much	  less	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time	  and	  effort	  if	  additional	  instructors	  participate,	  opening	  up	  more	  simulation	  
time	  slots	  and	  expediting	  the	  training	  process.	  Other	  institutions	  can	  also	  expect	  a	  
much	  higher	  rate	  of	  simulation	  participation,	  since	  all	  of	  their	  trainees	  will	  have	  
have	  ostensibly	  signed	  up	  for	  a	  simulation-­‐based	  experience.	  Our	  study	  population	  
was	  not	  aware	  of	  the	  course’s	  existence	  prior	  to	  the	  pre-­‐test	  and	  didactic	  
component,	  which	  was	  administered	  without	  warning	  to	  accurately	  measure	  
baseline	  knowledge.	  Thus,	  despite	  our	  best	  efforts	  to	  identify	  those	  most	  likely	  to	  be	  
involved	  in	  a	  brain	  death	  determination,	  we	  surely	  gave	  the	  didactic	  to	  many	  
physicians	  who	  felt	  that	  they	  would	  not	  gain	  much	  from	  our	  course.	  	  
	   In	  considering	  how	  to	  best	  implement	  our	  intervention	  at	  other	  sites,	  we	  
should	  contextualize	  it	  within	  existing	  programs.	  At	  present,	  there	  are	  two	  emerging	  
training	  courses	  in	  brain	  death	  determination.	  These	  courses,	  offered	  by	  the	  
Cleveland	  Clinic	  and	  the	  University	  of	  Chicago,	  represent	  opposite	  ends	  of	  the	  
spectrum	  in	  terms	  of	  rigor	  and	  generalizability.	  	  
The	  Cleveland	  Clinic	  course	  (32)	  is	  free,	  online,	  and	  intended	  for	  physicians,	  
fellows,	  and	  residents.	  The	  course	  takes	  approximately	  1	  hour	  to	  complete	  and	  
covers	  all	  aspects	  of	  brain	  death	  determination	  clearly	  and	  concisely.	  Each	  step	  of	  
the	  cranial	  nerve	  examination	  is	  illustrated	  through	  videos,	  showing	  responses	  
consistent/inconsistent	  with	  brain	  death.	  In	  addition	  to	  the	  examination,	  the	  course	  
provides	  information	  on	  documenting	  brain	  death	  and	  tools	  for	  discussing	  brain	  
death	  with	  families.	  An	  outline	  of	  the	  laws	  and	  accepted	  medical	  standards	  for	  each	  
state	  is	  also	  provided.	  The	  benefit	  of	  this	  web-­‐based	  approach	  is	  its	  potential	  for	  
wide	  impact	  –	  the	  course	  can	  be	  administered	  at	  minimal	  cost,	  and	  it	  can	  reach	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many	  institutions	  that	  would	  otherwise	  have	  little	  or	  no	  exposure	  to	  a	  
contemporary	  brain	  death	  training	  course.	  A	  drawback	  is	  the	  lack	  of	  hands-­‐on	  
experience	  or	  feedback	  on	  clinical	  skills	  in	  the	  context	  of	  an	  evolving	  clinical	  
scenario,	  which	  can	  only	  be	  gained	  through	  a	  simulation-­‐based	  experience	  or	  on-­‐
the-­‐job	  training.	  	  
On	  the	  opposite	  end	  of	  the	  spectrum	  is	  the	  University	  of	  Chicago	  Brain	  Death	  
Simulation	  Workshop	  (33),	  which	  is	  a	  full	  day	  training	  course	  intended	  to	  provide	  
participants	  with	  a	  comprehensive,	  simulation-­‐based	  experience.	  The	  workshop	  is	  
run	  yearly	  in	  Chicago	  and	  has	  20	  slots	  available	  for	  interested	  faculty,	  fellows,	  or	  
residents	  in	  neurology,	  neurosurgery,	  critical	  care,	  trauma	  surgery,	  and	  emergency	  
medicine.	  Simulation	  stations	  provide	  hands-­‐on	  experience	  with	  the	  brain	  death	  
exam,	  including	  proper	  management	  in	  the	  setting	  of	  a	  hemodynamic	  crisis	  or	  
diabetes	  insipidus.	  The	  workshop	  also	  includes	  opportunities	  to	  discuss	  brain	  death	  
with	  professional	  actor	  “families.”	  Complementing	  these	  simulations	  are	  lectures	  
and	  case	  studies	  emphasizing	  various	  brain	  death	  concepts.	  All	  activities	  are	  highly	  
structured	  and	  staffed	  by	  expert	  faculty	  members	  who	  provide	  personalized	  
feedback.	  The	  clear	  strength	  of	  this	  course	  lies	  in	  its	  comprehensiveness	  –	  it	  
provides	  participants	  with	  unparalleled	  hands-­‐on	  learning	  under	  the	  supervision	  of	  
expert	  faculty.	  The	  limitations	  of	  this	  course	  are	  associated	  with	  its	  scale	  –	  only	  20	  
physicians	  can	  be	  trained	  per	  year,	  at	  a	  cost	  of	  $500-­‐1000	  per	  physician.	  The	  impact	  
of	  this	  workshop,	  therefore,	  relies	  on	  the	  ability	  of	  trained	  physicians	  to	  transmit	  the	  
expertise	  they	  have	  gained	  to	  their	  home	  and	  surrounding	  institutions.	  We	  believe	  
that	  participants	  who	  have	  completed	  this	  workshop	  are	  ideal	  candidates	  to	  become	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“champions,”	  and	  operate	  a	  smaller	  scale	  course	  –	  such	  as	  the	  one	  described	  herein–	  
at	  their	  home	  institutions.	  	  
Our	  course	  lies	  between	  these	  two	  with	  regard	  to	  resource	  and	  learning	  
intensity,	  as	  it	  combines	  a	  short,	  easily	  replicable	  didactic	  session	  with	  a	  hands-­‐on	  
learning	  experience	  in	  a	  manner	  that	  can	  be	  delivered	  to	  substantial	  numbers	  of	  
participants	  at	  once.	  As	  outlined	  above,	  participants	  typically	  devote	  only	  about	  one	  
and	  a	  half	  hours	  to	  the	  course,	  and	  derive	  a	  significant	  amount	  of	  benefit	  from	  their	  
time	  investment.	  We	  strongly	  believe	  that	  our	  model	  provides	  the	  correct	  level	  of	  
rigor	  to	  train	  a	  core	  nucleus	  of	  clinicians	  at	  any	  hospital.	  	  
However,	  limitations	  to	  widespread	  dissemination	  of	  our	  intervention	  
include	  that	  it	  was	  implemented	  at	  a	  major	  teaching	  hospital	  with	  resources	  such	  as	  
a	  staffed	  simulation	  center,	  which	  may	  limit	  applicability	  to	  other	  institutions.	  At	  
Yale,	  we	  also	  had	  a	  neurointensivist	  who	  was	  fully	  dedicated	  to	  this	  project	  and	  the	  
countless	  hours	  of	  lectures	  and	  simulation	  required	  to	  see	  it	  to	  completion.	  Our	  
hope	  is	  that	  other	  institutions	  will	  recognize	  the	  need	  to	  improve	  upon	  clinician	  
competence	  and	  standardization	  of	  brain	  death	  determination,	  and	  heed	  the	  “call	  to	  
action”	  that	  has	  been	  echoed	  in	  our	  community	  so	  often	  in	  recent	  years.	  
Partnerships	  with	  neighboring	  institutions	  for	  resource	  sharing	  will	  be	  essential	  in	  
achieving	  this	  end.	  	  
Our	  immediate	  goal	  is	  to	  finish	  training	  all	  physicians	  involved	  in	  brain	  death	  
determination	  at	  our	  institution.	  In	  doing	  so,	  we	  will	  work	  to	  further	  hone	  our	  
intervention	  to	  ensure	  its	  optimal	  effectiveness.	  More	  broadly,	  we	  aim	  to	  train	  all	  
interested	  physicians	  in	  our	  region,	  which	  includes	  Connecticut,	  New	  York,	  Rhode	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Island,	  and	  Massachusetts.	  For	  physicians	  in	  the	  immediate	  area	  capable	  of	  driving	  
to	  Yale-­‐New	  Haven	  Hospital	  (YNHH),	  we	  will	  be	  able	  to	  schedule	  30-­‐minute	  
simulation	  time	  slots	  on	  an	  individual	  basis.	  Our	  brain	  death	  experts	  could	  give	  the	  
didactic	  session	  to	  a	  large	  group	  at	  their	  local	  hospital,	  or	  it	  could	  be	  arranged	  to	  
take	  place	  at	  YNHH.	  Eventually,	  we	  may	  replace	  the	  didactic	  with	  a	  video	  lecture	  or	  
online	  mini-­‐course	  that	  participants	  could	  complete	  before	  arriving	  for	  their	  
simulation.	  This	  would	  further	  enhance	  participant	  knowledge	  prior	  to	  the	  
simulation,	  and	  would	  eliminate	  the	  need	  to	  coordinate	  the	  didactic	  sessions.	  For	  
physicians	  travelling	  to	  YNHH	  from	  greater	  distances,	  we	  plan	  to	  hold	  multiple	  half-­‐
day	  sessions.	  These	  sessions	  will	  consist	  of	  a	  group	  didactic	  portion	  followed	  by	  
multiple	  simultaneous	  simulation	  exercises	  led	  by	  several	  of	  our	  staff	  
neurointensivists,	  who	  will	  be	  appropriately	  trained	  in	  brain	  death	  determination	  
and	  simulation.	  At	  YNHH,	  we	  have	  5	  SimMan	  3G	  simulators	  and	  6	  neurointensivists	  
boarded	  in	  neurocritical	  care,	  which	  would	  allow	  for	  5	  simultaneous	  sessions.	  	  
Using	  this	  model,	  our	  aim	  is	  to	  train	  75-­‐100	  physicians	  every	  6	  months,	  with	  
the	  ultimately	  goal	  of	  training	  300-­‐400	  physicians	  over	  the	  next	  two	  years.	  We	  are	  
currently	  in	  the	  process	  of	  applying	  for	  an	  R18	  grant	  to	  fund	  this	  exciting	  expansion	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Doctor,	  the	  patient,	  Mr.	  Jones,	  is	  a	  54-­‐year-­‐old	  man	  S/P	  prolonged	  cardiac	  arrest	  48	  
hours	  ago.	  He	  has	  not	  received	  any	  paralytics,	  induced	  hypothermia,	  or	  sedating	  
medications.	  His	  cervical	  spine	  has	  been	  cleared	  from	  injury.	  He	  has	  no	  significant	  
acid-­‐base,	  endocrine,	  electrolyte	  disorders	  or	  hyperammonemia.	  He	  is	  no	  longer	  
overbreathing	  the	  set	  rate	  on	  the	  ventilator.	  	  
	  
Vitals:	  BP	  120/75	   HR	  80	   	  	  	  	  	  Temp	  34°C	  	  	  	  	  	  	  	  	  	  	  	  O2	  saturation	  	  	  98%	  
	  
Vent	  settings:	  Assist	  Control	  Ventilation	   RR	  20	  	  	  	  	  TV	  750	  	  	  	  	  FiO2	  50%	  	  	  	  PEEP	  5	  
	  
Most	  recent	  ABG:	   pH	  7.54	  	  	  	  	  	  	  	  	  pCO2	  30	  	  	  	  	  	  	  pO2	  110	  
	  
CXR:	  wnl	   	  
	  
CT:	  diffuse	  cerebral	  edema	  severe	  enough	  to	  cause	  cerebral	  circulatory	  arrest	  and	  
death	  
	  
Doctor,	  you	  can	  do	  a	  complete	  brain	  death	  exam	  on	  this	  patient,	  including	  an	  apnea	  
test.	  You	  may	  safely	  perform	  all	  aspects	  of	  the	  evaluation.	  If	  you	  need	  any	  additional	  
information	  or	  equipment,	  please	  let	  me	  know.	  Please	  note	  that	  time	  is	  adjusted	  for	  the	  
purposes	  of	  this	  examination:	  for	  example,	  if	  you	  change	  one	  parameter	  you	  may	  get	  a	  
response	  in	  2	  seconds	  that	  represents	  5	  minutes	  or	  even	  one	  day.	  Please	  note	  that	  the	  
patient	  may	  or	  may	  not	  be	  truly	  brain	  dead.	  I	  will	  function	  as	  a	  nurse	  and	  as	  a	  





-­‐	  If	  they	  choose	  to	  decrease	  the	  RR	  or	  TV	  now:	  Doctor,	  the	  ABG	  is	  now	  7.38/42/90.	  	  
	  
-­‐	  If	  they	  also	  choose	  to	  increase	  FiO2	  to	  100%:	  Doctor,	  the	  ABG	  is	  now	  7.38/42/270.	  
	  
-­‐	  If	  no	  changes	  are	  made,	  ABG	  stays	  the	  same	  until	  apnea	  testing.	  	  
	  
Fig.	  1	  Initial	  prompt,	  including	  vitals,	  oxygen	  saturation,	  ventilator	  settings,	  and	  a	  
recent	  ABG.	  Three	  possible	  ABG	  values	  are	  listed	  here	  based	  on	  initial	  changes	  made	  
in	  ventilator	  settings.	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Fig.	  4	  Pre-­‐test	  scores	  (%)	  among:	  A)	  attendings	  and	  B)	  residents,	  by	  specialty.	  Mean	  
score	  among	  all	  providers	  on	  the	  pre-­‐test	  was	  43.1%	  (n=111).	  Ane,	  anesthesia;	  Crit	  
Care,	  critical	  care;	  EM,	  emergency	  medicine;	  Neuro,	  neurology;	  Neurocrit,	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Fig.	  6	  Simulation	  scores	  (%)	  on	  the	  clinical	  exam	  and	  apnea	  test	  by	  specialty,	  
including	  both	  residents	  and	  attendings.	  Mean	  simulation	  score	  among	  all	  
participants	  was	  67.2%	  (n=38).	  Ane,	  anesthesia;	  Neuro,	  neurology;	  Neurocrit,	  





Fig.	  7	  Common	  omissions	  in	  the	  simulation	  exercise.	  Uncover	  ext:	  uncovers	  
extremities	  during	  clinical	  exam;	  Uncover	  torso:	  uncovers	  torso	  during	  apnea	  test;	  
Blink:	  tests	  blink	  to	  visual	  threat;	  Position	  HOB:	  positions	  head	  of	  bed	  at	  30°	  for	  
oculovestibular	  reflex	  testing;	  Bolus/DDAVP:	  provides	  fluid	  bolus	  or	  DDAVP	  to	  
correct	  central	  diabetes	  insipidus.	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Fig.	  8	  Areas	  of	  strength	  in	  the	  simulation	  exercise.	  Oculocephalic	  reflex:	  tests	  
oculocephalic	  reflex;	  decreases	  minute	  ventilation:	  action	  performed	  at	  beginning	  of	  
apnea	  test	  to	  achieve	  eucapnea;	  detaches	  vent,	  O2	  via	  suction	  cath:	  action	  
performed	  at	  beginning	  of	  apnea	  test	  to	  start	  CO2	  challenge;	  ABG:	  asks	  for	  ABG	  at	  
the	  end	  of	  the	  apnea	  test;	  declares	  brain	  death:	  recognizes	  that	  ABG	  is	  consistent	  






Fig.	  9	  Pre-­‐Test	  and	  Post-­‐Test	  scores	  among	  simulation	  participants,	  by	  question	  
category.	  In	  this	  group,	  mean	  scores	  on	  the	  pre-­‐test	  and	  post-­‐test	  were	  45.4%	  and	  
73.3%,	  respectively.	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Table	  1.	  Specialty	  and	  level	  of	  training	  of	  didactic	  and	  simulation	  participants.	  	  	  
	  
Level	  of	  Training	  
	  	  	  	  	  Specialty	  
All	  Participants	  	  
(n	  =	  111)	  
Simulation	  Participants	  
(n	  =	  38)	  
Attending	   51	   21	  
	  	  	  	  	  Anesthesia	   4	   2	  
	  	  	  	  	  Critical	  Care	  Medicine	   5	   0	  
	  	  	  	  	  Emergency	  Medicine	   1	   0	  
	  	  	  	  	  Neurocritical	  Care	   7	   2	  
	  	  	  	  	  Neurology	   19	   8	  
	  	  	  	  	  Neurosurgery	   5	   0	  
	  	  	  	  	  Trauma	  Surgery	   10	   9	  
Fellow	   2	   1	  
	  	  	  	  	  Critical	  Care	  Medicine	   1	   0	  
	  	  	  	  	  Neurology	   1	   1	  
Resident	   42	   15	  
	  	  	  	  	  Critical	  Care	  Medicine	   1	   0	  
	  	  	  	  	  Emergency	  Medicine	   13	   0	  
	  	  	  	  	  Neurology	   19	   12	  
	  	  	  	  	  Neurosurgery	   9	   3	  
Physician	  Assistant	   3	   1	  
	  	  	  	  	  Critical	  Care	  Medicine	   1	   0	  
	  	  	  	  	  Anesthesia	   1	   0	  
	  	  	  	  	  Neurology	   1	   1	  
Nurse	  	   8	   0	  
Critical	  Care	   5	   0	  
Other	   3	   0	  
Student	  (Medicine,	  PA)	   6	   0	  
	  
	  
